Need For New Drugs Keeps Pharmaceutical Scientists' Pay High

Salaries for most pharmaceutical scientists rose in 1989, reflecting the ongoing development of new drug products and the need to keep pace with inflation, according to the latest annual survey conducted by the American Association of Pharmaceutical Scientists. The 5,350-member association, based in Alexandria, Va., represents a wide range of science professionals who design, test, market, and develop drugs. For scientists working in industry--the bulk of those responding--1989 salaries rose

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Salaries for most pharmaceutical scientists rose in 1989, reflecting the ongoing development of new drug products and the need to keep pace with inflation, according to the latest annual survey conducted by the American Association of Pharmaceutical Scientists. The 5,350-member association, based in Alexandria, Va., represents a wide range of science professionals who design, test, market, and develop drugs.

For scientists working in industry--the bulk of those responding--1989 salaries rose 3.4 percent over 1988 pay, to a mean of $63,200. Similarly, pharmaceutical scientists working in academia received pay hikes of 6.5 percent, to a mean of $58,800.

The association sent questionnaires to more than 4,600 of its members between April and July 1990. Of these, 1,854 replied, amounting to a 40 percent response rate. About 63 percent of the respondents held a Ph.D. Seventy-four percent worked in private industry, and 23 percent worked for universities. Most respondents had between 11 ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Edward Silverman

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo